AURA Aura Biosciences, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Aura Biosciences, Inc. (AURA) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 30, 2026, a 10-Q quarterly report filed on May 11, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Aura Biosciences, Inc. (AURA) (SEC CIK 1501796), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Aura Biosciences, Inc.
Ask AI about AURA filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting AURA positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on AURA.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate AURA share value held by 13F filers tracked by SignalX, by quarter.
- Millennium Management+480.3K (+78%)
- Dimensional Fund Advisors+40.2K (+8%)
- Goldman Sachs Group+38.8K (+28%)
- State Street Corp+38.1K (+4%)
- AQR Capital Management+32.3K (+233%)
- Citadel Advisors LLC56.0K (-82%)
- Renaissance Technologies LLC43.1K (-30%)
- Bank of America Corp39.8K (-24%)
- Wells Fargo & Co32.1K (-65%)
- Citigroup22.4K (-64%)
- Franklin Resources+2.07M
- Fifth Third Bancorp+488
- Vanguard Group Inc−2.94M
- Invesco Ltd−27.3K
- JPMorgan Chase & Co−23.1K
Source: 13F-HR filings on SEC EDGAR (aggregated from 135 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest AURA SEC filings in 2026?
Aura Biosciences, Inc. (AURA) has filed a 10-K annual report on March 30, 2026, a 10-Q quarterly report on May 11, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did AURA file its most recent 10-K annual report?
Aura Biosciences, Inc. (AURA) filed its most recent 10-K annual report on March 30, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view AURA 10-Q quarterly reports?
Aura Biosciences, Inc. (AURA)'s most recent 10-Q quarterly report was filed on May 11, 2026. SignalX displays every AURA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has AURA filed recently?
Aura Biosciences, Inc. (AURA)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find AURA insider trading activity (Form 4)?
SignalX aggregates every AURA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does AURA file with the SEC?
Aura Biosciences, Inc. (AURA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AURA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Aura Biosciences, Inc. (AURA).
What is AURA's SEC CIK number?
Aura Biosciences, Inc. (AURA)'s SEC CIK (Central Index Key) number is 1501796. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1501796 to look up all AURA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Aura Biosciences, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 38+ filings.